Posterior reversible encephalopathy syndrome;Das posteriore reversible Enzephalopathiesyndrom

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 111, Issue 5, 2016, Pages 417-424

  Fischer, M ^a   Schmutzhard, E ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Universitatsklinik fur Neurochirurgie Innsbruck   (Austria)

Author keywords

Autoimmune diseases; Chemotherapy; Hypertensive encephalopathy; Imaging; Pre eclampsia

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BACTERIAL TOXIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; VASOCONSTRICTOR AGENT; AUTACOID;

ARTERIAL PRESSURE; ARTERY PERFUSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOREGULATION; BLOOD BRAIN BARRIER; BLOOD PRESSURE FLUCTUATION; BRAIN HEMORRHAGE; DIFFERENTIAL DIAGNOSIS; EPILEPTIC STATE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; ISCHEMIA; NEUROIMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREECLAMPSIA; SEPSIS; VASOCONSTRICTION; BLOOD; BLOOD PRESSURE; BRAIN; CAPILLARY LEAK SYNDROME; INTENSIVE CARE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

BLOOD PRESSURE; BRAIN; CAPILLARY LEAK SYNDROME; CRITICAL CARE; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; VASOCONSTRICTION;

EID: 84975215479     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-016-0175-7     Document Type: Article

References (31)

1. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043–1049
2. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036–1042
3. Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28:1320–1327
4. Bartynski WS, Tan HP, Boardman JF et al (2008) Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 29:924–930
5. Burnett MM, Hess CP, Roberts JP et al (2010) Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 112:886–891
6. Havenon A de, Joos Z, Longenecker L et al (2014) Posterior reversible encephalopathy syndrome with spinal cord involvement. Neurology 83:2002–2006
7. Feske S (2011) Posterior reversible encephalopathy syndrome: a review. Semin Neurol 31:202–215
8. Fugate JE, Claassen DO, Cloft HJ et al (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432
9. Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14:914–925
10. Granata G, Greco A, Iannella G et al (2015) Posterior reversible encephalopathy syndrome – Insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev 14:830–836
11. Hammerstrom AE, Howell J, Gulbis A et al (2013) Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. Am J Hematol 88:301–305
12. Hayes D, Adler B, Turner TL, Mansour HM (2014) Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation. Pediatr Neurol 50:272–275
13. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500
14. James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee [JNC 8. JAMA 311:507–520
15. Kastrup O, Schlamann M, Moenninghoff C et al (2015) Posterior reversible encephalopathy syndrome: the spectrum of MR imaging patterns. Clin Neuroradiol 25:161–171
16. Kontos HA, Wei EP, Navari RM et al (1978) Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 234:H371–83
17. Kozak OS, Wijdicks EFM, Manno EM et al (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69:894–897
18. Lamy C, Oppenheim C, Mas JL (2014) Posterior reversible encephalopathy syndrome. Handb Clin Neurol 121:1687–1701
19. Lassen NA (1971) Regulation of cerebral circulation. Acta Anaesthesiol Scand Suppl 45:78–80
20. Lee VH, Wijdicks EFM, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65:205–210
21. MacKenzie ET, Strandgaard S, Graham DI et al (1976) Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 39:33–41
22. Marra A, Vargas M, Striano P et al (2014) Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypotheses 82:619–622. doi:10.1016/j.mehy.2014.02.022
23. Masetti R, Cordelli DM, Zama D et al (2015) PRES in children undergoing hematopoietic stem cell or solid organ transplantation. Pediatrics 135:890–901
24. McKinney AM, Sarikaya B, Gustafson C, Truwit CL (2012) Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol 33:896–903
25. McKinney AM, Short J, Truwit CL et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189:904–912
26. Meng L, Gelb AW (2015) Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology 122:196–205
27. Postma IR, Slager S, Kremer HPH et al (2014) Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature. Obstet Gynecol Surv 69:287–300
28. Vincent J‑L (2011) Annual update in intensive care and emergency medicine 2011, 1. Aufl. Springer, Heidelberg
29. Wu Q, Marescaux C, Wolff V et al (2010) Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation. Eur Neurol 64:169–177
30. Yamamoto H, Natsume J, Kidokoro H et al (2015) Clinical and neuroimaging findings in children with posterior reversible encephalopathy syndrome. Eur J Paediatr Neurol 19:672–678
31. Yamauchi A, Ieiri I, Kataoka Y et al (2002) Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 [MDR1] gene. Transplantation 74:571–572